Trial Profile
Effects of ipilimumab in patients with metastatic melanoma: A biomarker retrospective study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Jan 2016
Price :
$35
*
At a glance
- Drugs Ipilimumab (Primary)
- Indications Malignant melanoma
- Focus Pharmacodynamics
- 19 Jan 2016 New trial record